Twist Bioscience (TWST) Financial Statements & Analysis

Twist Bioscience (TWST) Income Statement

Twist Bioscience reported revenue of $376.57M in fiscal 2025 (fiscal year ended Sep 30, 2025), up 20.3% from $312.97M a year earlier. Twist Bioscience posted a net loss of $77.67M, compared with a net loss of $208.73M a year earlier. Gross margin was 50.7% and operating margin -36.2%. In the most recent quarter, Q3 fiscal 2026 (ended Jun 30, 2026), revenue was $118.38M, up 23.2% from the same quarter a year earlier.

Twist Bioscience Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Twist Bioscience Corporation income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017
Revenue & Gross Profit
Revenue	376.57	312.97	245.11	203.57	132.33	90.10	54.39	25.43	10.77
Cost of Revenue	185.57	179.63	155.38	119.33	80.62	61.41	47.43	32.19	24.02
Gross Profit	191.00	133.35	89.73	84.24	51.71	28.69	6.96	-6.76	-13.25
Operating Expenses
Research & Development	80.29	90.85	106.89	120.31	69.07	43.01	35.68	20.35	19.17
Selling, General & Administrative	246.98	218.40	189.74	212.95	135.90	103.27	80.13	43.45	26.06
Operating Expenses	327.26	354.18	306.89	333.26	204.44	168.77	115.81	63.80	45.23
Operating Income	-136.26	-220.83	-217.16	-249.02	-152.73	-140.08	-108.85	-70.56	-58.48
Other Income/Expense
Interest Income	11.36	15.34	14.37	3.06	0.44	1.50	3.03	1.00	0.41
Interest Expense	0.00	0.03	0.01	0.08	0.37	0.79	1.29	1.31	0.91
Other Income/Expense	59.31	12.67	13.69	17.77	-1.30	0.53	1.47	-0.44	-0.55
Income
Income Before Tax	-76.95	-208.17	-203.47	-228.27	-154.03	-139.55	-107.38	-70.99	-59.03
Income Tax Expense	0.72	0.56	1.15	-10.41	-1.93	0.38	0.29	0.24	0.28
Net Income	-77.67	-208.73	-204.62	-217.86	-152.10	-139.93	-107.67	-71.24	-59.31
Net Income - Continuous Operations	-77.67	-208.73	-204.62	-217.86	-152.10	-139.93	-107.67	-71.24	-59.31
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	-114.31	-176.71	-177.59	-211.68	-143.91	-132.09	-99.77	-63.95	-53.10
EBIT	-136.26	-175.90	-206.90	-228.19	-153.26	-	-	-	-
Depreciation & Amortization	21.95	31.43	29.31	16.51	9.75	6.68	6.31	5.73	5.02
Earnings Per Share
Basic EPS	-1.00	-4.00	-4.00	-4.00	-3.00	-4.00	-4.00	-3.00	-3.00
Diluted EPS	-1.00	-4.00	-4.00	-4.00	-3.00	-4.00	-4.00	-3.00	-3.00
Basic Shares Outstanding	59.81	58.02	56.89	53.89	48.25	39.19	27.46	26.61	18.78
Diluted Shares Outstanding	59.81	58.02	56.89	53.89	48.25	39.19	27.46	26.61	18.78

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Twist Bioscience Financial Statements

What was Twist Bioscience's revenue in fiscal 2025?

Twist Bioscience reported revenue of $376.57M in fiscal 2025 (fiscal year ended Sep 30, 2025). That was up 20.3% from $312.97M a year earlier.

Is Twist Bioscience profitable?

No. Twist Bioscience reported a net loss of $77.67M in fiscal 2025. In fiscal 2024 it lost $208.73M.

What is Twist Bioscience's operating margin?

Twist Bioscience's operating income was −$136.26M on revenue of $376.57M in fiscal 2025, an operating margin of -36.2%, compared with -70.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition